Ranjeet Ajmani Invites You To Join The AABB-AATM Joint Webinar on Plasma Fractionation
Ranjeet Ajmani, Chief Executive Officer- Asia at Aegros, shared on LinkedIn:
”Plasma-Derived Medicinal Products (PDMPs) are life-saving therapies used to treat a wide range of medical conditions, including immune deficiencies, bleeding disorders, and various rare diseases.
These products are derived from human plasma, which can be collected in two ways: by separating it from donated whole blood (Recovered Plasma) or through a dedicated plasma donation process (Source Plasma).
The manufacturing of PDMPs involves a highly specialized and strictly regulated process called plasma fractionation, where different plasma proteins are separated and purified for therapeutic use.
Since plasma is the primary raw material for these products, ensuring its high quality and safety is of utmost importance.”
Stay informed on all coming webinars and seminars in Hematology with Hemostasis Today.
-
Sep 22, 2026, 16:20Ila Bappa Ibrahim: Bringing Sickle Cell Innovation Closer to Communities
-
Sep 22, 2026, 16:02Ana Pedrero Gil: Peri-operative Management of Patients Undergoing Day Surgery
-
Sep 22, 2026, 15:27Zia Ullah: RBC-Derived Extracellular Vesicles as Potential Biomarkers of Thrombotic Risk in Dengue
-
Sep 22, 2026, 15:01Lesley Van Wyk: What Each Iron Markers Actually Mean
-
Sep 22, 2026, 14:37Chokri Ben LamineÖ‰ Saudi Arabia Leads A New Milestone In Hemophilia A Care
-
Sep 22, 2026, 13:58Giulia Passaniti: Dual Inferior Vena Cava Anatomy in Tetralogy of Fallot
-
Sep 22, 2026, 13:35Michael Miyamoto: Scaling Guideline Based Lipid Management in Community Practice
-
Sep 22, 2026, 13:15Suvro Sankha Datta: Developing Blood Group Genotyping Platform Using a Gold-Oligo
-
Sep 22, 2026, 13:07Caitlin Raymond: The Plasma Chaser in Therapeutic Plasma Exchange